Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | PARP inhibitors for ovarian cancer

Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, OK, talks about the treatment landscape of ovarian cancer with the emergence of PARP inhibitors. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.